Scientist II/Senior Scientist Nonclinical Development
Epicrispr Biotechnologies(13 days ago)
About this role
An early-stage biotech focused on epigenome regulation derived from CRISPR innovations is hiring a Scientist II/Senior Scientist in Nonclinical Development. The role supports translation of gene therapy candidates from research through clinical-enabling studies and reports to the VP of Therapeutics. This position works closely with platform, bioanalytical, and CMC teams to advance programs toward regulatory submissions.
Required Skills
- Gene Therapy
- GLP Studies
- Pharmacology
- Biodistribution
- Toxicology
- Regulatory Affairs
- CRO Management
- Bioanalysis
- Biomarkers
- Project Management
+1 more
Qualifications
- Ph.D. in Medicinal Chemistry, Pharmacology, or Related Discipline
About Epicrispr Biotechnologies
epicrispr.comEpicrispr Biotechnologies is a biotech company focused on CRISPR-based gene editing and precision genetic medicine. They develop editing platforms and delivery approaches designed to correct disease-causing mutations and generate therapeutic candidates for inherited and acquired disorders. The company partners with academic and industry collaborators to translate programs toward clinical development with attention to safety, specificity, and scalable manufacturing. Their stated mission—"The future of genetic medicine is epic"—emphasizes bringing durable, transformative therapies to patients.
Apply instantly with AI
Let ApplyBlast auto-apply to jobs like this for you. Save hours on applications and land your dream job faster.
Similar Jobs
Vice President, Nonclinical and Clinical Pharmacology
Mirum Pharmaceuticals(28 days ago)
Director/Sr. Director, Clinical Pharmacology
BridgeBio Pharma(6 days ago)
Scientist / Senior Scientist, DMPK
Altos Labs(4 days ago)
Assistant Project Scientist - Small Molecule
Celerion(1 year ago)
Pioneering Medicines: Principal Scientist / Associate Director , Non-Clinical Pharmacology
Flagship Pioneering, Inc.(1 month ago)
Associate Director/Director of Preclinical Development
Kernal Biologics, Inc.(7 days ago)